Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer that develops rapidly and often does not form a distinct lump like other breast cancers.
Florida Cancer Specialists & Research Institute hosts its 2025 Clinical Summit, bringing oncology leaders together to advance patient care, research, and collaboration across Florida.
Florida Cancer Specialists & Research Institute earns ACR accreditation for all 11 radiation oncology sites, highlighting excellence in safety and patient care.
Inflammatory Breast Cancer – Summary, Symptoms, TreatmentsInflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer that develops rapidly and often does not form a distinct lump like other breast cancers.
FCS Champions the Impact of Integrated Oncology At NCODA International SummitFlorida Cancer Specialists & Research Institute physician leaders and pharmacy experts share insights at 2025 NCODA International Fall Summit.
Oncology Leaders Champion Innovation and Collaboration To Advance Cancer Care FCS Hosts 2025 Clinical SummitFlorida Cancer Specialists & Research Institute hosts its 2025 Clinical Summit, bringing oncology leaders together to advance patient care, research, and collaboration across Florida.
Raising the Bar in Community Cancer Care: FCS Radiation Oncology Sites Earn ACR AccreditationFlorida Cancer Specialists & Research Institute earns ACR accreditation for all 11 radiation oncology sites, highlighting excellence in safety and patient care.
FCS Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity ThreatsFCS earns HITRUST i1 Certification, demonstrating strong cybersecurity and data protection practices across its pharmacy and data systems.
Breast Cancer in the Millennial EraWomen in their 20s and 30s, are receiving cancer diagnoses, and their cancer is often at more advanced stages. Learn More.
FCS Physician Leaders Examine Best Practices To Improve Speed, Efficiency & Reduce Cost In Bringing Anti-cancer Medicines to PatientsFCS physician abstract co-authors examine best practices to improve speed, efficiency & reduce cost in bringing anti-cancer medicines to patients.